Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News 9342-8530 Quebec Inc DGCRF

Healthcare Biotechnology
Diagnocure Inc is a Canada based biotechnology company. It is primarily engaged in the business activity of development and commercialization of products relating to the diagnosis of cancer. The group generates its revenue from research and license agreement. The head office of the company is located in Quebec, Canada.

Recent & Breaking News (GREY:DGCRF)

Mid-Afternoon Market Update: NASDAQ Down 1%; LendingTree Shares Spike Higher

Benzinga.com  July 27, 2017

Mid-Afternoon Market Update: Crude Oil Up 3%; Seagate Shares Drop After Q4 Miss

Benzinga.com  July 25, 2017

20 Biggest Mid-Day Losers For Tuesday

Benzinga.com  July 25, 2017

Mid-Day Market Update: Dow Rises Over 100 Points; Team Shares Plummet

Benzinga.com  July 25, 2017

DiagnoCure announces results of its Annual and Special Meeting of shareholders

Canada NewsWire May 19, 2016

IIROC Trade Resumption - DiagnoCure Inc.

Newsfile April 15, 2016

IIROC Trade Resumption - CUR

Canada NewsWire April 15, 2016

Diagnocure announces its decision to proceed with the voluntary Liquidation and Dissolution of the Corporation

Canada NewsWire April 15, 2016

IIROC Trade Halt - DiagnoCure Inc.

Newsfile April 15, 2016

IIROC Trading Halt - CUR

Canada NewsWire April 15, 2016

DiagnoCure Announces First Quarter 2016 Results

Canada NewsWire March 11, 2016

DiagnoCure announces closing of the PCA3 Asset Sale transaction and special distribution to its shareholders, by way of due bills, of proceeds from the sale of its PCA3 assets

Canada NewsWire February 17, 2016

DiagnoCure announces results of the special meeting of its shareholders

Canada NewsWire February 12, 2016

DiagnoCure reports recommendations from two independent proxy advisory firms favorable to the PCA3 asset sale and to the reduction of the stated capital

Canada NewsWire February 2, 2016

DiagnoCure announces fourth quarter 2015 and year-end results as well as proxy circular filing and business initiatives following the execution of an asset purchase agreement to sell all its assets relating to PCA3

Canada NewsWire January 21, 2016

DiagnoCure announces the execution of an Asset Purchase Agreement

Canada NewsWire December 23, 2015

DiagnoCure announces third quarter 2015 results

PR Newswire September 11, 2015

DiagnoCure announces second quarter 2015 results and restructures its Board of directors

Canada NewsWire June 12, 2015

DiagnoCure's new prostate cancer multimarker urine test featured at a recent press event of the American Urological Association

Canada NewsWire May 20, 2015

DiagnoCure announces results of its Annual and General Meeting of shareholders

PR Newswire April 30, 2015